BCAB
Income statement / Annual
Last year (2023), BioAtla, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, BioAtla, Inc.'s net income was -$123.46 M.
See BioAtla, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00
|
$0.00
|
$250,000.00
|
$429,000.00
|
$5.20 M
|
$10.63 M
|
| Cost of Revenue |
$103.73 M |
$1.20 M |
$1.33 M |
$19,933.00 |
$25,919.00 |
$26.31 M |
| Gross Profit |
-$103.73 M |
-$1.20 M |
-$1.08 M |
$409,067.00 |
$5.17 M |
-$15.68 M |
| Gross Profit Ratio |
0 |
0 |
-4.32 |
0.95 |
1 |
-1.48 |
| Research and Development
Expenses |
$103.73 M
|
$79.35 M
|
$58.27 M
|
$19.93 M
|
$25.92 M
|
$26.31 M
|
| General & Administrative
Expenses |
$25.96 M
|
$28.79 M
|
$38.42 M
|
$10.60 M
|
$7.55 M
|
$12.56 M
|
| Selling & Marketing
Expenses |
-$1.22 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$25.96 M
|
$28.79 M
|
$38.42 M
|
$10.60 M
|
$7.55 M
|
$12.56 M
|
| Other Expenses |
$0.00 |
$10,000.00 |
$1,000.00 |
-$1,000.00 |
-$22,000.00 |
-$5,000.00 |
| Operating Expenses |
$26.04 M |
$108.14 M |
$96.69 M |
$30.53 M |
$33.47 M |
$38.86 M |
| Cost And Expenses |
$129.77 M |
$108.14 M |
$96.69 M |
$30.53 M |
$33.47 M |
$38.86 M |
| Interest Income |
$6.31 M |
$1.65 M |
$350,000.00 |
$100,000.00 |
$128,000.00 |
$209,000.00 |
| Interest Expense |
$0.00 |
-$1.66 M |
$3,000.00 |
$1.39 M |
$1.63 M |
$949,000.00 |
| Depreciation &
Amortization |
$1.22 M
|
$1.20 M
|
$1.33 M
|
$1.01 M
|
$860,000.00
|
$794,000.00
|
| EBITDA |
-$128.47 M
|
-$106.48 M
|
-$94.76 M
|
-$28.99 M
|
-$27.30 M
|
-$27.24 M
|
| EBITDA Ratio |
0 |
0 |
-379.04 |
-67.58 |
-5.25 |
-2.56 |
| Operating Income Ratio
|
0
|
0
|
-385.76
|
-70.16
|
-5.44
|
-2.66
|
| Total Other
Income/Expenses Net |
$6.23 M
|
$1.66 M
|
$1.04 M
|
-$5.75 M
|
-$1.59 M
|
-$5,000.00
|
| Income Before Tax |
-$123.46 M |
-$106.48 M |
-$95.40 M |
-$35.85 M |
-$29.86 M |
-$28.98 M |
| Income Before Tax Ratio
|
0
|
0
|
-381.61
|
-83.57
|
-5.74
|
-2.73
|
| Income Tax Expense |
$0.00 |
-$1.20 M |
$4,000.00 |
$1.39 M |
$1.55 M |
$204,000.00 |
| Net Income |
-$123.46 M |
-$105.28 M |
-$95.41 M |
-$37.24 M |
-$31.40 M |
-$28.98 M |
| Net Income Ratio |
0 |
0 |
-381.62 |
-86.81 |
-6.04 |
-2.73 |
| EPS |
-2.58 |
-2.7 |
-2.76 |
-1.11 |
-0.93 |
-1.34 |
| EPS Diluted |
-2.58 |
-2.7 |
-2.76 |
-1.11 |
-0.93 |
-1.34 |
| Weighted Average Shares
Out |
$47.78 M
|
$38.93 M
|
$34.56 M
|
$33.66 M
|
$33.66 M
|
$21.59 M
|
| Weighted Average Shares
Out Diluted |
$47.78 M
|
$38.93 M
|
$34.56 M
|
$33.66 M
|
$33.66 M
|
$21.59 M
|
| Link |
|
|
|
|
|
|
